| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IMMUNI.2005.09.010 |
| P698 | PubMed publication ID | 16286017 |
| P2093 | author name string | Katsuhiko Ishihara | |
| Toshio Hirano | |||
| Nobuhiko Katunuma | |||
| Masaaki Murakami | |||
| Sung-Joo Park | |||
| Hidemitsu Kitamura | |||
| Hokuto Kamon | |||
| Shin-Ichiro Sawa | |||
| P433 | issue | 5 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 491-502 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells | |
| P478 | volume | 23 |
| Q64973042 | A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy. |
| Q48480933 | Abnormal microglial activation in the Cstb(-/-) mouse, a model for progressive myoclonus epilepsy, EPM1. |
| Q52353619 | Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts |
| Q60112422 | Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period |
| Q33772651 | Antigen-Specific CD4+ T Cells Regulate Function of Myeloid-Derived Suppressor Cells in Cancer via Retrograde MHC Class II Signaling |
| Q79935369 | Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells |
| Q33578030 | Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM |
| Q97525881 | Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors |
| Q61813961 | Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells |
| Q92963134 | Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy |
| Q44234805 | Cathepsin K Is Involved in Development of Psoriasis-like Skin Lesions through TLR-Dependent Th17 Activation |
| Q37363448 | Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells |
| Q35865581 | Cellular immunotherapy using dendritic cells against multiple myeloma |
| Q39593840 | Coordinated involvement of cathepsins S, D and cystatin C in the commitment of hematopoietic stem cells to dendritic cells. |
| Q36691086 | Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. |
| Q37782230 | Cystatin C in acute kidney injury |
| Q38341202 | Cystatin C is a disease-associated protein subject to multiple regulation |
| Q52573372 | Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials |
| Q30429045 | Cytokines regulate cysteine cathepsins during TLR responses |
| Q34997011 | Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function |
| Q37564269 | Diverse regulatory roles for lysosomal proteases in the immune response |
| Q41785517 | Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells. |
| Q33839267 | Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling |
| Q88301302 | Dysfunction of antigen processing and presentation by dendritic cells in cancer |
| Q39886394 | Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles |
| Q47437302 | Elevated Wall Tension Initiates Interleukin-6 Expression and Abdominal Aortic Dilation |
| Q36563605 | Endothelial cells and cathepsins: Biochemical and biomechanical regulation |
| Q37417083 | Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells |
| Q46952190 | Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity |
| Q55425641 | Hsa-miR-99b/let-7e/miR-125a Cluster Regulates Pathogen Recognition Receptor-Stimulated Suppressive Antigen-Presenting Cells. |
| Q61632990 | Human hyper-IgE syndrome: singular or plural? |
| Q92960461 | Hydrogen Sulfide Prevents Elastin Loss and Attenuates Calcification Induced by High Glucose in Smooth Muscle Cells through Suppression of Stat3/Cathepsin S Signaling Pathway |
| Q48090319 | Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity. |
| Q35852574 | Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve? |
| Q38574966 | In vivo induction of regulatory T cells for immune tolerance in hemophilia |
| Q36346817 | In-vitro Validation of Cytokine Neutralizing Antibodies by Testing with Ovine Mononuclear Splenocytes |
| Q40141836 | Increased cathepsin S in Prdm1-/- dendritic cells alters the TFH cell repertoire and contributes to lupus. |
| Q43063757 | Induction of STAT3-related genes in fast degenerating cone photoreceptors of cpfl1 mice. |
| Q64241678 | Interferon-γ Receptor Signaling in Dendritic Cells Restrains Spontaneous Proliferation of CD4 T Cells in Chronic Lymphopenic Mice |
| Q52319515 | Interleukin-6 is a key factor for immunoglobulin-like transcript-4-mediated immune injury in sepsis |
| Q42288627 | Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy |
| Q27301176 | Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization |
| Q49885401 | Involvement of Cystatin C in Immunity and Apoptosis. |
| Q33818803 | Keratinocytes determine Th1 immunity during early experimental leishmaniasis |
| Q38659916 | Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy. |
| Q24321398 | Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway |
| Q33882051 | Molecular Control of Steady-State Dendritic Cell Maturation and Immune Homeostasis |
| Q38918609 | Molecular mechanisms involved in dendritic cell dysfunction in cancer |
| Q38205157 | Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells. |
| Q64126081 | Neuropeptide Signaling Activates Dendritic Cell-Mediated Type 1 Immune Responses through Neurokinin-2 Receptor |
| Q53621799 | Neutrophil direction sensing and superoxide production linked by the GTPase-activating protein GIT2. |
| Q54617418 | PD‐L1 expression on tolerogenic APCs is controlled by STAT‐3 |
| Q53383447 | Piperine Inhibits Lipopolysaccharide‐induced Maturation of Bone‐marrow‐derived Dendritic Cells Through Inhibition of ERK and JNK Activation |
| Q52565516 | Plasma inflammatory cytokines and survival of pancreatic cancer patients |
| Q37717709 | Regulation of CD4 T-cell receptor diversity by vaccine adjuvants |
| Q37982182 | Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells |
| Q38205362 | STAT3 Target Genes Relevant to Human Cancers |
| Q48235101 | STAT3 expression by myeloid cells is detrimental for the T- cell-mediated control of infection with Mycobacterium tuberculosis. |
| Q89157989 | STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity |
| Q38844774 | STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis. |
| Q38835846 | STAT3 signaling in immunity |
| Q93079065 | STAT3, a Master Regulator of Anti-Tumor Immune Response |
| Q36481079 | STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance |
| Q56889963 | Sperm Protein 17 Expression by Murine Epithelial Ovarian Cancer Cells and Its Impact on Tumor Progression |
| Q34598268 | Structure-based development of specific inhibitors for individual cathepsins and their medical applications |
| Q43101212 | TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation |
| Q90540850 | Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution |
| Q37012605 | Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma |
| Q45711562 | The Key Role of IL-6–Arginase Cascade for Inducing Dendritic Cell–Dependent CD4+ T Cell Dysfunction in Tumor-Bearing Mice |
| Q83204973 | The unveiling of hidden T-cell determinants of a native antigen by defined mediators of inflammation: implications for the pathogenesis of autoimmunity |
| Q80066570 | Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function |
| Q35916009 | Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission |
| Q39137392 | Tumor-Derived Vascular Pericytes Anergize Th Cells |
| Q35032491 | Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer |
| Q83691511 | Tumors Suppress In Situ Proliferation of Cytotoxic T Cells by Promoting Differentiation of Gr-1+ Conventional Dendritic Cells through IL-6 |
| Q33729335 | Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression |
| Q37177705 | Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice |
| Q35165486 | Urinary biomarkers and renal recovery in critically ill patients with renal support |
| Q34036863 | Yeast two-hybrid screening of proteins interacting with plasmin receptor subunit: C-terminal fragment of annexin A2 |
Search more.